Amit Kumar Halder


AuthID: R-00J-AZS

Confirmed Publications: 61



31
TITLE: Insight into the structural requirements of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors by multiple validated 3D QSAR approaches  Full Text
AUTHORS: Halder, AK ; Amin, SA; Jha, T; Gayen, S;
PUBLISHED: 2017, SOURCE: SAR and QSAR in Environmental Research, VOLUME: 28, ISSUE: 3
INDEXED IN: Scopus CrossRef: 21
IN MY: ORCID
32
TITLE: Possible anticancer agents: synthesis, pharmacological activity, and molecular modeling studies on some 5-N -Substituted-2-N-(substituted benzenesulphonyl)-L(+)Glutamines  Full Text
AUTHORS: Jha, T; Basu, S; Halder, AK ; Adhikari, N; Samanta, S;
PUBLISHED: 2017, SOURCE: Medicinal Chemistry Research, VOLUME: 26, ISSUE: 7
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
33
TITLE: Ligand- and structure- based drug design of non- steroidal aromatase inhibitors (NSAIs) in breast cancer
AUTHORS: Jha, T; Halder, AK ; Adhikari, N; Saha, A;
PUBLISHED: 2016, SOURCE: Oncology: Breakthroughs in Research and Practice, VOLUME: 1-2
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
34
TITLE: Nitric oxide synthase (NOS) inhibitors in cancer angiogenesis
AUTHORS: Halder, AK ; Mukherjee, A; Adhikari, N; Saha, A; Jha, T;
PUBLISHED: 2016, SOURCE: Current Enzyme Inhibition, VOLUME: 12, ISSUE: 1
INDEXED IN: Scopus
IN MY: ORCID
35
TITLE: Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays  Full Text
AUTHORS: Adhikari, N; Halder, AK ; Mallick, S; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2016, SOURCE: Bioorganic and Medicinal Chemistry, VOLUME: 24, ISSUE: 18
INDEXED IN: Scopus CrossRef: 47
IN MY: ORCID
36
TITLE: Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents  Full Text
AUTHORS: Mondal, C; Halder, AK ; Adhikari, N; Saha, A; Saha, KD; Gayen, S; Jha, T;
PUBLISHED: 2015, SOURCE: European Journal of Medicinal Chemistry, VOLUME: 90
INDEXED IN: Scopus CrossRef: 22
IN MY: ORCID
37
TITLE: Design of dual MMP-2/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity
AUTHORS: Halder, AK ; Mallick, S; Shikha, D; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2015, SOURCE: RSC Advances, VOLUME: 5, ISSUE: 88
INDEXED IN: Scopus CrossRef: 52
IN MY: ORCID
38
TITLE: Ligand-and structure-based drug design of non-steroidal aromatase inhibitors (NSAIs) in breast cancer
AUTHORS: Jha, T; Adhikari, N; Halder, AK ; Saha, A;
PUBLISHED: 2015, SOURCE: Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment
INDEXED IN: Scopus CrossRef: 4
IN MY: ORCID
39
TITLE: Recent advances in multi-task QSAR modeling for drug design
AUTHORS: Halder, AK ; Goodarzi, M;
PUBLISHED: 2015, SOURCE: Pharmaceutical Sciences, VOLUME: 21, ISSUE: 4
INDEXED IN: Scopus CrossRef
IN MY: ORCID
40
TITLE: Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation
AUTHORS: Halder, AK ; Saha, A; Saha, KD; Jha, T;
PUBLISHED: 2015, SOURCE: Journal of Biomolecular Structure and Dynamics, VOLUME: 33, ISSUE: 8
INDEXED IN: Scopus CrossRef: 16
IN MY: ORCID
Page 4 of 7. Total results: 61.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service